Reducing eDiscovery risk for Pharmaceutical Companies

This webinar on reducing eDiscovery risks will describe an effective strategy, that pharmaceutical companies can follow, to minimize the costs associated with litigation and eDiscovery based on records management concepts.

Why Should You Attend:

Pharmaceutical and Biotech companies are often involved with litigation concerned with either contractual issues with business partners or patent and trademark infringement. Adversaries often request documentation they may find relevant to their cases. This has driven the adoption of formal information retention programs and eDiscovery practices. Email is no longer the most commonly requested records companies must produce . Both structured and unstructured information sources have recently outranked email. Notably, too, is the rise in demands for access to social media and mobile phone text messages.

Areas Covered in the Seminar:

• Record policy and procedures.
• Disaster recovery versus records preservation.
• Instituting Records Management educational programs.
• Litigation hold – the essentials.
• Isolating, preserving and validating records in litigation hold.
• Methodology and techniques for analyzing records on hold.
• Approaches to handling comingled records.

Who Will Benefit:

• Research & Development
• Records Management
• Legal
• Information Technology
• Validation